"JLHL is a well-established multi-specialty healthcare provider in the western region of India, and it is planning to expand its operations in the future. The IPO was well-received by investors, with the issue being subscribed 64.8 times which led to such a good listing gain. Investors who participated in the IPO can now book profit while those who want to hold it long term may maintain a stop loss at around 875," Anubhuti Mishra, Equity Research Analyst at Swastika Investmart advised.Read more: